Anebulo Pharmaceuticals, Inc.(ANEB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANEB Anebulo Pharmaceuticals, Inc.

盘后交易 02-10 19:07:56 EST

0.4760

-0.0055

-1.14%

盘后0.4760

+0.00000.00%

16:04 EST

最高0.4830	最低0.4600	成交量3.91万
今开0.4624	昨收0.4815	日振幅4.78%
总市值1,956万	流通市值161.90万	总股本4,108万
成交额1.82万	换手率1.15%	流通股本340.13万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANEB","market":"US","secType":"STK","nameCN":"Anebulo Pharmaceuticals, Inc.","latestPrice":0.476,"timestamp":1770757200000,"preClose":0.4815,"halted":0,"volume":39063,"hourTrading":{"tag":"盘后","latestPrice":0.476,"preClose":0.476,"latestTime":"16:04 EST","volume":192,"amount":91.392,"timestamp":1770757477374,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0114226375908619,"floatShares":3401326,"shares":41084731,"eps":-0.224482,"marketStatus":"盘后交易","change":-0.0055,"latestTime":"02-10 19:07:56 EST","open":0.462358,"high":0.483,"low":0.46,"amount":18234.915826,"amplitude":0.047767,"askPrice":0.5145,"askSize":100,"bidPrice":0.45,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-0.224482,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770771600000},"marketStatusCode":4,"adr":0,"listingDate":1620360000000,"exchange":"NASDAQ","adjPreClose":0.4815,"preHourTrading":{"tag":"盘前","latestPrice":0.4738,"preClose":0.4815,"latestTime":"09:11 EST","volume":143,"amount":67.7534,"timestamp":1770732699834,"change":-0.0077,"changeRate":-0.015992,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.476,"preClose":0.476,"latestTime":"16:04 EST","volume":192,"amount":91.392,"timestamp":1770757477374,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.180925},"requestUrl":"/m/hq/s/ANEB/wiki","defaultTab":"wiki","newsList":[{"id":"1145174650","title":"Anebulo Pharmaceuticals宣布自愿从纳斯达克退市并向美国证券交易委员会申请注销登记","url":"https://stock-news.laohu8.com/highlight/detail?id=1145174650","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145174650?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:01","pubTimestamp":1770386507,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals, Inc. 已正式宣布，其计划自愿从纳斯达克证券交易所退市，并同时向美国证券交易委员会（SEC）提交申请，以注销其证券的登记。此举标志着公司资本市场监管策略的重大调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANEB","BK4007","BK4539"],"gpt_icon":0},{"id":"1190816779","title":"Anebulo Pharmaceuticals发布2025财年第四季度及全年财务业绩和最新动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1190816779","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190816779?lang=zh_cn&edition=full","pubTime":"2025-09-30 04:07","pubTimestamp":1759176434,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals发布2025财年第四季度及全年财务业绩和最新动态","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANEB","BK4539","BK4007"],"gpt_icon":0},{"id":"1172864147","title":"Anebulo Pharmaceuticals Inc计划推进召开特别股东大会以批准拟议的反向股票分割","url":"https://stock-news.laohu8.com/highlight/detail?id=1172864147","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172864147?lang=zh_cn&edition=full","pubTime":"2025-09-12 19:31","pubTimestamp":1757676676,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals Inc表示，公司计划继续推进召开特别股东大会，以便股东对拟议的反向股票分割方案进行投票表决。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANEB","BK4539"],"gpt_icon":0},{"id":"2512436656","title":"Anebulo Pharmaceuticals, Inc.盘中异动 下午盘股价大跌6.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512436656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512436656?lang=zh_cn&edition=full","pubTime":"2025-02-20 03:31","pubTimestamp":1739993469,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日03时31分，Anebulo Pharmaceuticals, Inc.股票出现异动，股价大幅下跌6.84%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220033110988b6055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220033110988b6055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANEB","BK4007","BK4539"],"gpt_icon":0},{"id":"2512694561","title":"Anebulo Pharmaceuticals, Inc.盘中异动 急速上涨9.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512694561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512694561?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:21","pubTimestamp":1739892062,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时21分，Anebulo Pharmaceuticals, Inc.股票出现异动，股价急速上涨9.77%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Allogene Therapeutics, Inc.、Solid Biosciences Inc.、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为356.55%、143.56%、135.66%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Allogene Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为148.75%、58.33%、51.40%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218232102a24ab801&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218232102a24ab801&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANEB","BK4007","BK4539"],"gpt_icon":0},{"id":"1130573635","title":"Anebulo Pharmaceuticals 2025年第二季度GAAP每股收益$(0.09)低于预期$(0.08)","url":"https://stock-news.laohu8.com/highlight/detail?id=1130573635","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130573635?lang=zh_cn&edition=full","pubTime":"2025-02-15 05:10","pubTimestamp":1739567417,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals公布其季度每股亏损$，低于分析师普遍预期的$，差距为12.5%。这比去年同期的每股亏损$减少了18.18%。以上内容来自Benzinga Earnings专栏，原文如下：Anebulo Pharmaceuticals  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 12.5 percent. This is a 18.18 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Anebulo Pharmaceuticals 2025年第二季度GAAP每股收益$(0.09)低于预期$(0.08)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANEB"],"gpt_icon":0},{"id":"2511571635","title":"Anebulo Pharmaceuticals, Inc.盘中异动 大幅下挫6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511571635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511571635?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:30","pubTimestamp":1739475022,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时30分，Anebulo Pharmaceuticals, Inc.股票出现异动，股价快速下跌6.94%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3195.52%、2029.60%、1234.10%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214033022988465b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214033022988465b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ANEB","BK4539"],"gpt_icon":0},{"id":"2510861396","title":"Anebulo Pharmaceuticals, Inc.盘中异动 股价大跌7.00%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510861396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510861396?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:26","pubTimestamp":1739201214,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时26分，Anebulo Pharmaceuticals, Inc.股票出现异动，股价急速下跌7.00%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210232654988083fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210232654988083fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","ANEB"],"gpt_icon":0},{"id":"2509726628","title":"Anebulo Pharmaceuticals, Inc.盘中异动 大幅下挫5.19%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509726628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509726628?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:29","pubTimestamp":1738945743,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时29分，Anebulo Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.19%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208002903961b4d44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208002903961b4d44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ANEB","BK4007"],"gpt_icon":0},{"id":"2509274094","title":"Anebulo Pharmaceuticals, Inc.盘中异动 早盘股价大涨9.55%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509274094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509274094?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:32","pubTimestamp":1738852355,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时32分，Anebulo Pharmaceuticals, Inc.股票出现波动，股价快速拉升9.55%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223235a23bce7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223235a23bce7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANEB","BK4539","BK4007"],"gpt_icon":0},{"id":"2509499532","title":"Anebulo Pharmaceuticals, Inc.盘中异动 股价大跌8.07%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509499532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509499532?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:40","pubTimestamp":1738701656,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时40分，Anebulo Pharmaceuticals, Inc.股票出现波动，股价急速下跌8.07%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.47%。其相关个股中，Mink Therapeutics, Inc.、Cingulate Inc C/Wts 10/12/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1960.70%、994.08%、588.87%，振幅较大的相关个股有Azitra Inc、Mink Therapeutics, Inc.、Omega Therapeutics, Inc.，振幅分别为123.99%、65.44%、59.42%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020504405696181099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020504405696181099&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ANEB","BK4007"],"gpt_icon":0},{"id":"2508122644","title":"Anebulo Pharmaceuticals, Inc.盘中异动 股价大涨7.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508122644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508122644?lang=zh_cn&edition=full","pubTime":"2025-02-04 03:02","pubTimestamp":1738609350,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日03时02分，Anebulo Pharmaceuticals, Inc.股票出现波动，股价快速拉升7.44%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Hcw Biologics Inc.、Invivyd, Inc.、Gh Research Plc涨幅较大，Hcw Biologics Inc.、Cyclerion Therapeutics, Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为722.19%、693.76%、468.91%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为170.13%、151.80%、63.94%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204030230abc13d07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204030230abc13d07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ANEB","BK4007"],"gpt_icon":0},{"id":"2507246036","title":"Anebulo Pharmaceuticals, Inc.股价上涨10.21% 市值涨168.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507246036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507246036?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:46","pubTimestamp":1738248390,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时46分，Anebulo Pharmaceuticals, Inc.股票出现波动，股价快速上涨10.21%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。其候选产品ANEB-001旨在在给药后1小时内逆转大麻素过量的负面影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022463096143f46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022463096143f46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ANEB","BK4539"],"gpt_icon":0},{"id":"2506480308","title":"Anebulo Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506480308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506480308?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:42","pubTimestamp":1737988922,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时42分，Anebulo Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.84%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127224202abba6224&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127224202abba6224&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ANEB","BK4007"],"gpt_icon":0},{"id":"2505864556","title":"Anebulo Pharmaceuticals, Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505864556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505864556?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:19","pubTimestamp":1737731966,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时19分，Anebulo Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.06%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为3164.78%、1751.22%、942.43%，振幅较大的相关个股有Evaxion Biotech As、Windtree Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为112.09%、66.25%、55.79%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124231927960f9735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124231927960f9735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ANEB","BK4539"],"gpt_icon":0},{"id":"2505732187","title":"Anebulo Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.99%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505732187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505732187?lang=zh_cn&edition=full","pubTime":"2025-01-23 00:29","pubTimestamp":1737563369,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日00时29分，Anebulo Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.99%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Nutriband Inc C/Wts 、Dermata Therapeutics Inc C/Wts 、Immunoprecise Antibodies Ltd.涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为910.63%、224.82%、71.69%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Immunoprecise Antibodies Ltd.、Nutriband Inc C/Wts ，振幅分别为53.51%、52.05%、50.39%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123002930986f8bcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123002930986f8bcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","ANEB"],"gpt_icon":0},{"id":"2505078452","title":"Anebulo Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505078452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505078452?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:48","pubTimestamp":1737492524,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时48分，Anebulo Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.03%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.75%。其相关个股中，Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为1744.91%、530.46%、192.26%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为103.72%、96.32%、69.14%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122044844a22aa3a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122044844a22aa3a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANEB","BK4007","BK4539"],"gpt_icon":0},{"id":"2503918796","title":"Anebulo Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.04%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503918796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503918796?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:46","pubTimestamp":1737038788,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时46分，Anebulo Pharmaceuticals, Inc.股票出现异动，股价大幅下跌6.04%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。其候选产品ANEB-001旨在在给药后1小时内逆转大麻素过量的负面影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011622462898688ef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011622462898688ef4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ANEB","BK4007"],"gpt_icon":0},{"id":"2503410647","title":"Anebulo Pharmaceuticals, Inc.盘中异动 股价大涨5.92%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503410647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503410647?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:36","pubTimestamp":1736951790,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时36分，Anebulo Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.92%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Os Therapies Incorporated、Lexaria Bioscience Corp.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Os Therapies Incorporated较为活跃，换手率分别为187.82%、71.51%、57.87%，振幅较大的相关个股有Os Therapies Incorporated、Onconetix, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 ，振幅分别为33.41%、16.94%、13.70%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152236309604b569&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152236309604b569&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","ANEB"],"gpt_icon":0},{"id":"2503507692","title":"Anebulo Pharmaceuticals, Inc.盘中异动 股价大涨5.96%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503507692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503507692?lang=zh_cn&edition=full","pubTime":"2025-01-15 01:48","pubTimestamp":1736876891,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日01时48分，Anebulo Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.96%。Anebulo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Anebulo Pharmaceuticals, Inc.公司简介：Anebulo Pharmaceuticals Inc是一家临床阶段的生物技术公司，该公司致力于为患有大麻素过量和物质成瘾的人开发新型解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501150148119603a04c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501150148119603a04c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ANEB","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anebulo.com","stockEarnings":[{"period":"1week","weight":-0.497},{"period":"1month","weight":-0.5776},{"period":"3month","weight":-0.7942},{"period":"6month","weight":-0.7994},{"period":"1year","weight":-0.6933},{"period":"ytd","weight":-0.5233}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Anebulo Pharmaceuticals, Inc.于2020年4月23日在特拉华州注册成立。他们是一家临床阶段的生物技术公司，开发大麻毒性治疗方法，如无意大麻中毒、急性大麻素中毒（“ACI”）和更广泛的急性大麻诱导疾病。他们的主要候选产品selonabant（前身为ANEB-001）旨在快速逆转大麻毒性的负面影响，缩短恢复时间。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.028934},{"month":2,"riseRate":0.6,"avgChangeRate":-0.083809},{"month":3,"riseRate":0.5,"avgChangeRate":0.022147},{"month":4,"riseRate":0.5,"avgChangeRate":-0.131968},{"month":5,"riseRate":0,"avgChangeRate":-0.232057},{"month":6,"riseRate":0.8,"avgChangeRate":0.301589},{"month":7,"riseRate":0.4,"avgChangeRate":0.058151},{"month":8,"riseRate":0.4,"avgChangeRate":0.024087},{"month":9,"riseRate":0.4,"avgChangeRate":-0.024505},{"month":10,"riseRate":0.4,"avgChangeRate":-0.074759},{"month":11,"riseRate":0.2,"avgChangeRate":-0.099239},{"month":12,"riseRate":0.8,"avgChangeRate":-0.042725}],"exchange":"NASDAQ","name":"Anebulo Pharmaceuticals, Inc.","nameEN":"Anebulo Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anebulo Pharmaceuticals, Inc.(ANEB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anebulo Pharmaceuticals, Inc.(ANEB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anebulo Pharmaceuticals, Inc.,ANEB,Anebulo Pharmaceuticals, Inc.股票,Anebulo Pharmaceuticals, Inc.股票老虎,Anebulo Pharmaceuticals, Inc.股票老虎国际,Anebulo Pharmaceuticals, Inc.行情,Anebulo Pharmaceuticals, Inc.股票行情,Anebulo Pharmaceuticals, Inc.股价,Anebulo Pharmaceuticals, Inc.股市,Anebulo Pharmaceuticals, Inc.股票价格,Anebulo Pharmaceuticals, Inc.股票交易,Anebulo Pharmaceuticals, Inc.股票购买,Anebulo Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anebulo Pharmaceuticals, Inc.(ANEB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anebulo Pharmaceuticals, Inc.(ANEB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}